Caas Capital Management LP Bellerophon Therapeutics, Inc. Transaction History

Caas Capital Management LP

  • $288 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$3.83 - $5.65 $374,957 - $553,135
-97,900 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$5.07 - $8.27 $496,353 - $809,633
97,900 New
97,900 $508,000

Others Institutions Holding BLPH

# of Institutions
1
Shares Held
44K
Call Options Held
0
Put Options Held
0
View Full List

About Bellerophon Therapeutics, Inc.

BLPH Quotes by TradingView
  • Ticker BLPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,545,450
  • Market Cap $477K
  • Description
  • Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...
More about BLPH
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email